SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shukra Pharmaceuticals informs about updates

18 Mar 2025 Evaluate
Shukra Pharmaceuticals has informed that in continuation to the communication dated March 17, 2025 with respect to Sub-Division of Equity Shares from the Face Value of Rs 10 each to Face Value of Rs 1 each fully paid up with effect from Record Date, March 21, 2025. Further informed that the Sub-Division of Equity Shares will take effect under the new ISIN i.e. INE551COLO44. It has attached the ISIN activation letter, received today, March 18, 2025 from the National Securities Depository Limited and Central Depository Services (India). This is in terms of Regulation 30, Regulations 42 and any other applicable regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2025.

The above information is a part of company’s filings submitted to BSE.

SHUKRA-RE Share Price

20.40 0.00 (0.00%)
23-Feb-2023 18:02 View Price Chart
Peers
Company Name CMP
NGILPP 18.06
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×